Natco Chief Executive Rajeev Nannapaneni

Novedades

India rejects Gilead’s Hepatitis C drug patent request

14 febrero, 2015
mgusredon

(Reuters) - India's patent office has rejected an application from U.S.-based Gilead Sciences Inc for its…